# Adjuvant HIPEC in High Risk Colon Cancer

> **NCT02231086** · PHASE3 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 204 (actual)

## Conditions studied

- Colorectal Neoplasms
- Peritoneal Neoplasms

## Interventions

- **PROCEDURE:** Adjuvant HIPEC (open/laparoscopic)
- **DRUG:** Standard adjuvant systemic chemotherapy
- **PROCEDURE:** Diagnostic laparoscopy

## Key facts

- **NCT ID:** NCT02231086
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2018-09
- **Final completion:** 2019-06-01
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231086, "Adjuvant HIPEC in High Risk Colon Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02231086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*